Medication following bariatric surgery for type 2 diabetes mellitus (BY-PLUS) study: rationale and design of a randomised controlled study
Introduction Bariatric surgery is an effective method of controlling glycaemia in patients with type 2 diabetes mellitus (T2DM) and obesity. Long-term studies suggest that although glycaemic control remains good, only 20%–40% of patients will maintain remission according to the American Diabetes Ass...
Saved in:
Main Authors: | Alexander Dimitri Miras, Carel le Roux, Alexis Sudlow, Ricardo Vitor Cohen, Hassan Kahal, Dimitri J Pournaras, Jill Townley, Helen Heneghan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/7/e054313.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rationale and design of Diabetes Prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study
by: Yoshiya Tanaka, et al.
Published: (2016-07-01) -
Application of Metabolomics to Study Effects of Bariatric Surgery
by: Paulina Samczuk, et al.
Published: (2018-01-01) -
Bariatric Surgery in Moderately Obese Patients: A Prospective Study
by: M. Cerci, et al.
Published: (2013-01-01) -
Rationale for Antioxidant Supplementation in Sarcopenia
by: Francesco Cerullo, et al.
Published: (2012-01-01) -
Quality Assessment of Systematic Review of the Bariatric Surgery for Diabetes Mellitus
by: Xinye Jin, et al.
Published: (2019-01-01)